14/04/2022

Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis

Summary

Background

We estimated COVID-19 vaccine effectiveness against SARS-CoV-2 infection and severe COVID-19 outcomes among individuals with immune-mediated inflammatory diseases in Ontario, Canada.

Matéria original

Anterior

Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment
Próxima

PipeCoV: a pipeline for SARS-CoV-2 genome assembly, annotation and variant identification